Tagged with Ascentage

China Pharma Roundup: Sinopharm Tops Brand Value Rankings; Simcere Splashes $565M on Alzheimer’s Drug; Innovent-Ascentage Tie-Up A Sign of Biotech Deals to Come?
Hong Kong Biotech IPOs since Listing Reform in April 2018
China Pharma News Roundup May 11th 2020
China: A New Decade
Chinese Oncology Biotechs to Watch
Dajun Yang – Chairman, Executive Director & CEO, Ascentage Pharma, China
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here